Thursday, 21 November 2019

Zydus gets final USFDA approval for Colesevelam Hydrochloride Tablets

10 October 2019 | News

This medication is used to lower cholesterol in people with high levels of cholesterol in the blood

Zydus Cadila has received the final approval from the USFDA to market Colesevelam Hydrochloride Tablets, (US RLD - Welchol), 625 mg. This medication is used along with a proper diet and exercise, to lower cholesterol in people with high levels of cholesterol in the blood. Lowering cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks.

It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

The group now has 273 approvals and has so far filed over 360 ANDAs since the commencement of the filing process in FY 2003-04.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account